Mental stress and anger may have clinical implications for patients with heart f...
Biosensors announced today the enrolment of the first patient in REFORM—a prospe...
A US survey released by patient advocacy group Heart-Valve-Surgery.com, with sup...
InnovHeart—developer of novel transcatheter mitral valve replacement (TMVR) syst...
The Journal of the American Heart Association (JAHA) has retracted a paper publi...
Thirty-day clinical outcomes from the FORWARD PRO international study of the...
CardioMech, developer of a transfemoral, transseptally delivered mitral valve re...
A meta-analysis of 24 randomised controlled trials assessing dual antiplatel...
Eko has announced a collaboration with AstraZeneca to accelerate the development...
The US Food and Drug Administration (FDA) has issued an emergency use author...
In this educational supplement, sponsored by Boston Scientific, Cardiovascular N...
As interventional cardiology continues to grow with higher risk patients and...
A German study of recently-recovered COVID-19 patients examined using magnetic r...
A three-year, investigator-led, prospective study of Japanese patients who r...
One-year outcomes of mitral valve-in-valve replacement using the Sapien 3 (E...
Keystone Heart has announced completion of the first worldwide commercial ca...
Use of non-steroidal anti-inflammatory drugs (NSAIDs) to treat first-time heart ...
The American College of Cardiology (ACC) is expanding its JACC family of peer-re...
The US Food and Drug Administration (FDA) has approved one-way digital data ...
Aortic valve replacement, using either transcatheter aortic valve implantati...
Caption Health, a developer of medical artificial intelligence (AI) technolo...
MyoKardia has announced that the US Food and Drug Administration (FDA) has grant...
Digital health and artificial intelligence (AI) company Eko has been awarded a U...
Genetic testing and counselling for inherited cardiovascular diseases may he...
Findings of a US investigation of clinician race and gender bias in decision...
Scitech has announced that the Inspiron coronary sirolimus eluting stent has rec...
Boston Scientific has received US Food and Drug Administration (FDA) approva...
LifeSignals Group has announced that it has received US Food and Drug Administra...
Azeem Latib (New York, USA) spoke to Cardiovascular News about a sub-analysi...
Philipp Lurz (Leipzig, Germany) speaks to Cardiovascular News abou...
LivaNova has announced that the advanced Perceval Plus sutureless surgical aorti...
Women taking beta blockers for hypertension with no prior history of cardiovascu...
A rise in the number of out-of-hospital cardiac arrests (OHCAs) correlated with ...
Edwards Lifesciences has announced approval from the US Food and Drug Admini...
The American Heart Association (AHA) has announced that its 2020 Scientific Sess...
Around half of COVID-19 patients who received an echocardiogram in-hospital show...
Revamp Medical has announced that the US Food and Drug Administration (FDA) has ...
ACIST Medical Systems has announced the global launch of its ACIST Navvus II Rap...
Venus Medtech has announced a collaboration to bring Pi-Cardia's Leaflex tec...
The European Association of Percutaneous Cardiovascular Interventions (EAPCI...
Janarthanan Sathanathan (Center for Heart Valve Innovation, St Paul’s Hospit...
Paragonix Technologies presented new clinical data at the American Transplant Co...
MedAlliance has announced enrollment of the first patient in its study of Se...
Jens Erik Nielsen-Kudsk (Aarhus, Denmark) speaks to Cardiovascular News abou...
Black patients who undergo percutaneous coronary intervention (PCI) are at an ...
Ancora Heart has been given US Food and Drug Administration (FDA) approval o...
The American Heart Association (AHA) has named Mitchell SV Elkind as preside...
Using an Impella device is contraindicated in patients with severe aortic st...
NuVera Medical has announced the initiation of the company's first-in-human ...
US national hospital- and surgeon-level inverse volume–outcome associations ...
Patients who have trouble sleeping after heart bypass surgery should go for a ...
US Food and Drug Administration (FDA) Investigational Device Exemption (IDE)...
Mid-term data continue to show non-inferiority of resting instantaneous wave...
A subanalysis of the Onyx One study found that cardiac death was significant...
Left atrial appendage occlusion (LAAO) using the Amplatzer Amulet (Abbott) d...
MedAlliance has been awarded CE mark for the Selution SLR 014 percutaneous trans...
BioCardia has announced that it has resumed cases in the CardiAMP Heart Fail...
The feasibility, safety, and efficiency of transcatheter aortic valve implan...
According to a press release, one-year total population clinical outcome dat...
The FABOLUS FASTER trial, which was presented at PCR e-Course 2020 and simul...
Felice Gragnano (Inselspital, Bern University Hospital, Bern, Switzerland) o...
Left atrial appendage occlusion (LAAO) improves clinical outcomes including ...
Sripal Bangalore (New York University Grossman School of Medicine, New York,...
One-year results from the TRILUMINATE study show that TriClip (Abbott) trans...
Clinical and imaging results at 12 months for the DynamX Novolimus-Eluting C...
A systematic two-stent approach in complex coronary bifurcation lesions is a...
Patients who crossed over from the sham control arm of the RADIANCE-HTN SOLO...
Full one-year follow-up from the Evolut Low Risk trial has upheld earlier findin...
Long-term clinical outcomes, including mortality, following an aortic valve-...
Use of the transseptal Evoque transmitral valve replacement (TMVR) system (E...
A comprehensive evaluation of mitral valve-in-valve (ViV) and valve-in-ring ...
The American College of Cardiology (ACC) and Society for Vascular Surgery (S...
Miracor Medical has announced the award of the CE mark for its latest genera...
Medtronic has been awarded CE mark for the use of the Evolut transcatheter a...
Voice analysis by a smartphone app can identify lung congestion in heart failure...
Proximo Medical has announced a partnership with digital health company Coal...
Abiomed has launched a virtual physician education programme, CAMP PCI (Coro...
Trainee interventional cardiologists have raised concerns that reductions in...
Telemedicine has come into its own during the pandemic. Sameer Mehta details...
Blue Sail Medical has completed the acquisition of Swiss based company NVT A...
MicroPort has been given CE approval for its PathBuilder Steerable Introduce...
The British Heart Foundation (BHF) is calling on the Government and the NHS ...
Abiomed has received investigational device exemption (IDE) from the US Food...
Biosensors International Group has announced the appointment of Keith G Oldr...
Collaboration between cardiothoracic and vascular surgeons is key to achievi...
Medtronic has received the CE mark for a one-month dual antiplatelet therapy...
Clinical and echocardiographic outcomes at 30 days and one year were similar...
Mitral and tricuspid valve technologies, aortic valve replacement, and the v...
The American College of Cardiology (ACC) is to host a weekly virtual meeting...
The European Society of Cardiology (ESC) has announced that the HFA Discoveries ...
COVID-19 linked to a near 40% drop in STEMI cases in US cath labs
Survey ...
COVID-19 linked to a near 40% drop in STEMI cases in US cath labs
Survey ...
A Bayesian analysis of EXCEL and other randomised controlled trials comparing co...
LivaNova have presented the first data from the Perceval sutureless implant ...
CeloNova BioSciences has announced that it has successfully completed enrolmen...
The annual Transcatheter Cardiovascular Therapeutics (TCT) meeting has become th...
The Society for Cardiovascular Angiography and Interventions (SCAI) and the ...
According to research published in JACC: Heart Failure, patients with heart ...
A press release reports that the Society of Cardiovascular Computed Tomograp...
According to a survey published in the Journal of Occupational and Environme...
In JACC: Heart Failure, Mathias Orban (Medizinische Klinik und Poliklinik I,...
Several studies have suggested that, across all countries, COVID-19 mortalit...
Data from more than 1,000 patients presented during the virtual Society for ...
Medtronic has that announced Jeffrey J Popma (Harvard Medical School; Beth Israe...
Edwards Lifesciences has received the CE mark for the PASCAL transcatheter v...
A study published in Circulation: Cardiovascular Interventions shows that ro...
A late-breaking clinical trial presented at the virtual Society for Cardiova...
Weili Xu (Department of Epidemiology and Biostatistics, School of Public Hea...
A study presented at the virtual Society for Cardiovascular Angiography and ...
A study presented yesterday at the virtual Society for Cardiovascular Angiog...
A novel, groundbreaking trial has examined the viability of telemedicine for r...
PCR has announced a new online initiative—e-Course 2020—that is to run onlin...
The Society for Cardiovascular Angiography and Interventions (SCAI) has publ...
MedAlliance has announced the award of its second CE mark: Selution SLR 014 ...
A survey published in The Annals of Thoracic Surgery find that despite being...
The American College of Cardiology (ACC) is start to collecting COVID-19 dat...
Royal Philips has announced that it has received 510(k) clearance from the U...
The US Food and Drug Administration (FDA) has expedited clearance of an upda...
Two-year data from the BIONYX trial show that all-comer patients who underwe...
According to a statement, Heart Valve Voice US is “deeply concerned” that the pa...
A joint UK-US research team is applying an artificial intelligence (AI) system t...
BioCardia has announced data from a recent animal study performed that, acco...
Corresponding author Valentin Fuster (Mount Sinai Heart, New York, USA) and ...
Boston Scientific has announced positive 12-month results from the PINNACLE ...
A BIBA MedTech Insights survey indicates that 50% of centres perfo...
Vishal Luther (final year cardiology registrar/ Electrophysiology fellow, Im...
The European Society of Cardiology (ESC) is, for the first time in its 70-ye...
According to recently presented TICO trial data, a press release reports, pa...
ZOLL Medical has received CE Mark approval to market and distribute its Supe...
The Society of Cardiovascular Computed Tomography (SCCT) has announced plans...
The American College of Cardiology (ACC) and other North American cardiology...
A study presented at EAPC Essentials 4 You—a virtual scientific platform of ...
LifeSignals has received CE mark approval for the LifeSignals ECG Remote Mon...
A necklace that detects abnormal heart rhythm will be showcased for the firs...
PCR has issued a statement announcing that it is officially cancelling the 2...
Recent studies have suggested that during the pandemic, there has been a dro...
A new study has found no significant differences in hospital mortality betwe...
Before the 1940s, the prognosis for babies born with complex congenital hear...
Prism Schneider (Cumming School of Medicine, University of Calgary, Calgary,...
Abiomed (maker of the Impella heart pump) has acquired Breethe, developer of...
New guidance from the American Academy of Neurology (AAN) recommends the clo...
On 18 March, the Centers for Medicare & Medicaid Services (CMS) recommen...
Robocath, which designs, develops and commercialises cardiovascular robotic ...
iRhythm Technologies has announced a virtual platform to support patients an...
Boston Scientific, according to a press release announcing the company’s Q1 ...
The Society for Cardiovascular Angiography and Interventions (SCAI) and Canadian...
A press release reports that the British Heart Foundation (BHF) and the Nati...
VisCardia has been granted Breakthrough Device Designation from the US Food ...
LivaNova has announced that several of its cardiopulmonary products are can ...
In the Journal of American College of Cardiology, Ehtisham Mahmud (Universit...
A press release reports that several of the world’s ventilator manufacturers hav...
New data suggest that a medical device that uses vitamin B2 and ultraviolet ligh...
Pi-Cardia has closed a US$27 million round of financing, led by Sofinnova Pa...
Proximo Medical has announced a partnership with Elucid Bioimaging, a develo...
Studies have shown that robotic percutaneous coronary intervention (PCI) wit...
In response to a recent American College of Cardiology (ACC) review that adv...
In the first of a series of webinars focusing on COVID-19, Society for Cardi...
The COVID-19 pandemic is hitting the world hard. Egypt, the most populous co...
Impulse Dynamics has announced the publication of the FIX-HF-5C2 study in Ci...
Enrique Ostrzega (University of Southern California, Los Angeles, USA) and c...
The US Food and Drug Administration (FDA) issued an emergency use authorisat...
Santiago Garcia (Minneapolis Heart Institute Foundation, Abbott Northwestern...
The American Heart Association (AHA) has compiled interim CPR guidelines to ...
In a brief report in Annals of Internal Medicine, Seongman Bae (Asan Medical...
Physicians recognised the importance of remote management for heart failure ...
In separate statements, the European Society of Cardiology (ESC) and America...
Abbott has received the CE mark for its TriClip transcatheter tricuspid valv...
Presidents of leading cardiac organisations, including the American Heart Associ...
Royal Philips has announced that the US government and Philips agreed to team up...
Mardil Medical has announced the successful completion of treatment for the ...
Shockwave Medical has completed enrolment in its US Food and Drug Administra...
Ahmed Bendary describes the findings of a meta-analysis published last month...
A soft robotic heart that is designed to replace the need for a heart transp...
At the 2019 European Association of Cardio-Thoracic Surgeons (EACTS) annual ...
Cardiovascular specialists from across the globe shared current knowledge an...
The American Heart Association (AHA), in conjunction with the American Assoc...
The reduced levels of angiotensin converting enzyme (ACE) 2 associated with card...
Edwards Lifesciences has temporarily paused new enrolments in its active piv...
The European Commission (EC) has adopted a proposal to postpone by one year ...
Athena Poppas (Providence, USA) is the new president of the American College...
Simon Ray, president of the British Cardiovascular Society (BCS), has told t...
In a new statement published on 2 April 2020, all 45 societies represented by th...
A raised troponin level in myocardial injury “greatly alters the prognosis adver...
The COVID-19 Cardiovascular Conference, hosted as a live webinar by The Impe...
Cardiologists from across Europe have shared their experience of having treated ...
The American College of Surgeons (ACS) today leapt to the defense of healthc...
Daniel M Philbin Jr has been named chair of the American College of Cardiolo...
The Imperial College Network of Excellence in Vascular Science at Imperial Colle...
According to Geu-Ru Hong (Division of Cardiology, Severance Cardiovascular H...
Results from the phase 2 MAVERICK-HCM clinical trial, presented at the Ameri...
The longest follow-up to date of patients with left main coronary artery dis...
Today at the American College of Cardiology/World Congress of Cardiology’s v...
Using the radial artery instead of the saphenous vein for patients undergoin...
Medtronic today announced positive results of the Onyx ONE Clear Study that ...
“More bleeding with background clopidogrel, even if not severe by adjudicati...
Transcatheter aortic valve implantation (TAVI) procedures had a high rate of...
Three months after undergoing renal denervation, patients with untreated hig...
Data from the National Cardiovascular Data Registry (NCDR) Left Atrial Appen...
In the POPULAR TAVI trial, patients with atrial fibrillation who took oral a...
During the first Featured Clinical Research session of the virtual American ...
In stable atherosclerosis, a combination of aspirin plus rivaroxaban provide...
Treatment with aspirin plus rivaroxaban following lower extremity revascular...
Today, during the Virtual American College of Cardiology (ACC) event (28–30 ...
During a Q&A section of a European Commission (EC) college meeting on 25...
A viewpoint in the Journal of the American Medical Association (JAMA) has of...
Cardiac injury is common among hospitalised patients with COVID-19, and is assoc...
The US Food and Drug Administration’s (FDA) Center for Devices and Radiological ...
The American Heart Association (AHA) has committed US$2.5 million to research ef...
The British Cardiovascular Intervention Society (BCIS) and the British Cardi...
The Society for Cardiology and Angiography Interventions (SCAI) has set up a...
CroíValve has announced the successful first human use of its Duo Tricuspid ...
A new Heart & Stroke guideline published today in the Canadian Medical Assoc...
A case series of US experience with COVID-19 has upheld suggestions of a link wi...
The US Food and Drug Administration (FDA) has issued an immediately-in-effec...
The first report on the impact of COVID-19 on heart transplant recipients ha...
Frailty is an independent predictor of morbidity, death, and increased costs aft...
The Society for Cardiovascular Angiography and Interventions (SCAI) has writ...
Data from a pilot imaging study of commissural alignment in trancatheter aor...
European CE mark has been awarded to the TriGUARD 3 cerebral embolic protect...
Portola Pharmaceuticals announced new data that they say reinforces the value of...
Early improvement in health status for patients in the COAPT trial who had t...
Patients who have a percutaneous coronary intervention (PCI) for chronic tot...
The novel left atrial appendage (LAA) closure device Appligator (Append Medi...
Abbott made history in January when it became the first company in the world...
The American College of Cardiology Scientific Session Together with World Congre...
Vascular remodelling may occur in response to sustained, regular exercise, sugge...
Abbott has received CE mark in Europe for the new FlexNav delivery system fo...
The New England Journal of Medicine (NEJM) has launched a review into the data f...
A short film (“Today is a Good Day”), which showcases the work of Aortic Dis...
NOTE: This video is ONLY available to watch in selected countries and geographie...
NOBLE finds PCI inferior to CABG at five years in left main disease
EXCEL...
NOBLE finds PCI inferior to CABG at five years in left main disease
EXCEL...
Paclitaxel drug coated balloons (DCB) for percutaneous treatment of coronary...
Findings from an interim analysis of PROTECT III have added to the evidence ...
CryoLife has received CE mark for the On-X Ascending Aortic Prosthesis (AAP)...
The US Food and Drug Administration (FDA) has cleared a new version of the LivaN...
Endotronix has announced the enrollment of the first two patients in the PRO...
A research project at the University of Leeds aiming to identify new drug tr...
Transcatheter aortic valve implantation (TAVI) is safe in the short term in ...
Patients who develop stage 3 acute kidney injury (AKI) following transcathet...
Biotronik has announced three-year data from the BIOFLOW-V trial, which were...
Append Medical, developer of the Appligator, a novel left atrial appendage (...
Edwards Lifesciences has announced a new goal for its philanthropic initiative, ...
A comparison of newer generation self-expanding valves (SEV) and balloon-exp...
Ablative Solutions has revealed that positive six-month results from the Per...
Cardiovalve has received US Food and Drug Administration (FDA) approval for ...
Last month, Abbott announced US Food and Drug Administration (FDA) approval ...
The news programme BBC Newsnight has made further claims that the EXCEL inve...
VitalConnect has announced the introduction of arrhythmia detection to its r...
Gregg W Stone (Icahn School of Medicine, Mount Sinai, New York, USA) address...
Nicolas van Mieghem (professor of interventional cardiology, department of c...
The US Food and Drug Administration (FDA) has authorised marketing of software t...
Biotronik has received CE mark certification for the Orsiro Mission drug-elu...
Philips has announced a new randomised controlled trial to assess percutaneo...
Scott Lim (Charlottesville, USA) talks to BLearning Cardio at PCR London Val...
Philippe Pibarot (Québec, Canada) talks to BLearning Cardio at PCR London V...
BioVentrix has received renewal of the highest priority reimbursement in Germa...
Extended 10-year follow-up has demonstrated that in patients with a high SYN...
The debate over the results of EXCEL shows no sign of abating, and there see...
Medtronic has announced that it will begin enrolment in a pilot study evaluating...
The US Food and Drug Administration (FDA) has granted Breakthrough Device De...
Rajiv Patni has been appointed as executive vice president and chief medical...
Frank Arko (Charlotte, USA) talks to VEITHtv at the VEITHsymposium 2019 (19...
Guy’s and St Thomas’ and Royal Brompton & Harefield NHS Foundation Trusts ar...
The Tendyne transcatheter mitral valve implantation (TMVI) system (Abbott) has r...
Highly-tweeted articles are 11 times more likely to be cited than less tweet...
David Hayes, former physician administrator at Mayo Clinic, Rochester, USA, ...
Open heart surgery remains the best option for young and middle-aged adults ...
Patients discharged three days after open heart surgery are not at increased...
NOTE: This video is ONLY available to watch in selected countries and geographie...
Terumo has announced the launch of a new randomised clinical trial: the ...
The largest study to date of the role of frailty indices after transcatheter...
The TASTE and TOTAL studies suggested that routine thombus aspiration in pat...
FEops has announced that the first patient has been enrolled in the physician-in...
George Adams (Raleigh, USA) talks to VEITHtv at the VEITHsymposium 2019 (19–...
Emboline has completed enrolment in its SAFEPASS 2 clinical study of the Emb...
BioCardia has received US Food and Drug Administration (FDA) 510(k) clearanc...
Spartan Bioscience, a maker of precision medicine diagnostic solutions, has ...
A secondary analysis of repeat revascularisation in the EXCEL trial has foun...
The Society of Thoracic Surgeons (STS) has issued a statement on the controv...
The American College of Cardiology (ACC) has announced several promotions and st...
Abbott has announced that the US Food and Drug Administration (FDA) has appr...
A retrospective registry comparing four self-expanding transcatheter heart v...
Abbott has announced US Food and Drug Administration (FDA) approval of a new...
B Braun has announced the appointment of Jean-Claude Dubacher as chairman an...
Proximo Medical is to partner with CeloNova Biosciences, supplier of the COB...
The European Association of Cardio-Thoracic Surgeons (EACTS) has issued a st...
The European Association of Cardio-Thoracic Surgeons (EACTS) has published a det...
Five-year data from the NOBLE trial have confirmed its earlier findings that...
The Society for Thoracic Surgeons (STS) and the European Association of Cardio-T...
The US Food and Drug Administration has granted Breakthrough Device designat...
Daiichi Sankyo Europe has announced outcomes from an observational study in main...
A pivotal, multicentre clinical trial is exploring the use of an Impella hea...
Edwards Lifesciences has received the CE mark for its Sapien 3 transcatheter...
Gregg Stone (The Zena and Michael A Wiener Cardiovascular Institute, Icahn Schoo...
George Dangas (Mount Sinai Hospital, New York, USA) told delegates in a late...
The European Association of Cardio-Thoracic Surgery (EACTS) has wi...
InnovHeart—a developer of novel transcatheter mitral valve replacement (TMVR) sy...
Data from the CAP and CAP2 registries—which contain the longest and largest ...
Bioventrix has announced online publication of positive one-year results fro...
The TASTE and TOTAL studies suggested that routine thombus aspiration in pat...
A significant milestone has been reached for a landmark study into...
Michael Reardon (Houston, USA) talks to BLearning Cardio about the ADAPT tissue ...
The largest trial to date to compare revascularisation with a conservative s...
Preprocedural administration of an oral colchicine load does not reduce the ...
Meril has announced positive data on its Myval Transcatheter Heart Valve Sys...
Corindus has announced the completion of the first multicity, transcontinent...
The Revivent transcatheter ventricular enhancement system (Bioventrix) has b...
An analysis of structural valve deterioration in the PARTNER 2A trial has fo...
The use of TriClip (Abbott) for edge-to-edge repair in tricuspid regurgitati...
Permanent pacemaker implantation (PPI) after transcatheter aortic valve implanta...
Endotronix has presented first-in-human data of the Cordella pulmonary arter...
A single-centre real world experience has found that the vast majority of patien...
Over the past few years, the indications for transcatheter aortic valve impl...
The mortality risk for patients with critical limb ischaemia (CLI) has not c...
Shockwave Medical has initiated the DISRUPT CAD IV study of its intravascula...
A wrist-based optical blood pressure monitor has the potential to replace cu...
The use of multiphase computed tomography (CT) assessment, particularly duri...
A prespecified subgroup analysis of the GLOBAL LEADERS trial has found no be...
Left atrial appendage closure (LAAC) via implanted device was associated wit...
The 2019–20 president of the Society for Cardiovascular Angiography and Inte...
Patients who have mixed aortic valve disease with pre-existing aortic regurg...
CorFlow Therapeutics has announced that the company has been granted Breakth...
Cardionovum's Restore paclitaxel-coated balloon for coronary applications ha...
The stockholders of Corindus Vascular Robotics have approved the adoption of...
Further evidence for a shorter duration of dual antiplatelet therapy (DAPT) ...
Using optical coherence tomography (OCT)-to guide percutaneous coronary inte...
Different strategies are needed to address the continuing lack of diversity ...
A study published as a research letter in JAMA Internal Network has found a ...
Clinical data presented at the 2019 European Cardio-Thoracic Surgery (EACTS)...
The National Institute for Health and Care Excellence (NICE) has published the f...
Shockwave Medical, a company which provides intravascular lithotripsy (IVL) ...
William W Pinsky and Mandeep R Mehra explain to Cardiovascular News how inte...
This content is only for readers outside of the US as it discusses a device ...
During a session on radiation protection technologies at the 2019 Transcathe...
Admedus has sold the distribution rights to its CardioCel and VascuCel produ...
Penumbra has announced the enrolment of the first patient into the CHEETAH s...
Douglas Drachman has been selected as the next vice chair of the American Co...
Cardiothoracic surgeon David Taggart (Department of Cardiac Surgery, Univers...
Abiomed has announced the results of PROTECT III, an ongoing, prospective, s...
Data from an interim analysis of heart failure patients treated in the CorCi...
A prespecified analysis of data from the AUGUSTUS study, released at late-br...
The Gore Cardioform Occluder for atrial septal defects (ASD) has received CE...
Interest in transseptal puncture has surged with the development of structur...
Endotronix has announced the expansion of its series D financing round, brin...
ONYX ONE, the first randomised trial to compare a durable polymer drug-eluti...
A subanalysis of PARTNER 3 quality of life data demonstrated a modest, but s...
A timing substudy of the COMPLETE trial has found that, compared with culpri...
The MitraClip device (Abbott) continues to demonstrate safety and efficacy a...
The first randomised trial to compare the safety and efficacy of the Acurate...
The Portico IDE study has found that 30-day safety and one-year effectivenes...
Data from the TWILIGHT study demonstrate that, compared to ticagrelor plus a...
The US Food and Drug Administration (FDA) has approved the Evolut PRO+ trans...
In our September issue, we report on the top stories from the 2019 European Soci...
In our September issue, we report on the top stories from the 2019 European Soci...
The August issue of Cardiovascular News covers the top stories from EuroPCR 2019...
The August issue of Cardiovascular News covers the top stories from EuroPCR 2019...
Ashok Seth (New Delhi, India) talks to BLearning at EuroPCR 2019 (21–24 May, P...
Boston Scientific has announced the key data that will be presented at the T...
Corindus Is to showcase the CorPath GRX system at the Transcatheter Cardiova...
Abbott has announced its TRILUMINATE pivotal trial to evaluate the safety an...
AtriCure has entered into a definitive agreement to acquire SentreHEART, whi...
Martin Kostelka (Leipzig, Germany), who was the first to use the CardioCel 3...
Caution: This content is only for readers outside of France and Japan. In th...
Omar Ishrak, Medtronic’s chairman and CEO is to retire on 26 April 2020, fol...
A new study indicates that the Meridian transcatheter aortic valve implantat...
Merit Medical Systems, a leading manufacturer and marketer of proprietary de...
Virtual patient care is creating exciting learning opportunities for interve...
New data from the SwedeHF heart failure registry indicates that the use of a...
At the European Society of Cardiology Congress (ESC 2019; 31 August–4 Septem...
One-year data from the BIOSTEMI study, simultaneously published in The Lance...
Speaking to Cardiovascular News at the ECHSA 2019 meeting (European Congenit...
This morning at the 2019 European Society of Cardiology (ESC) Congress (31 A...
A strategy of complete revascularisation was superior to culprit lesion-only...
Stefanie Schüpke (Deutsches Herzzentrum München, and Technische Universität ...
At the 2019 European Society Cardiology (ESC) congress (31 August – 4 Septem...
Giovanni Stellin (Padova, Italy) talks to Cardiovascular News at the ECHSA 2...
Although renal denervation may not hit the heights originally envisaged for it i...
A polypill that combines four cardiovascular drugs has been shown to reduce the ...
AstraZeneca has announced positive results from the Phase III DAPA-HF trial ...
CeloNova has announced the appointment of Carl J St. Bernard as president and ch...
The US Food and Drug Administration has approved the Barostim Neo system for...
Horst Sievert (Frankfurt, Germany) talks to BLearning at EuroPCR 2019 (21–24...
According to a BIBA MedTech survey, 52% of neurointerventionalists believe t...
On 16 August, the US Food and Drug Administration (FDA) approved Edwards Lif...
Edwards Lifesciences—in a press statement announcing its global second quart...
The Cardiovascular Research Foundation (CRF) has announced the 12 late-breaking ...
The Myval transcatheter aortic valve implantation (TAVI) system, designed an...
Tomasz Mroczek (Kraków, Poland) talks to Cardiovascular News at ECHSA 2019 ...
Cardiovascular Systems recently announced that it has acquired the Wirion em...
Data from two new studies suggest that transcatheter tricuspid valve repair ...
Hormone replacement therapy is a common treatment for menopause-related symptoms...
B Braun Interventional Systems has announced that the US Food and Drug Administr...
The National Institute for Health and Care Excellence (NICE) in the UK has publi...
Ulrich Schäfer (Hamburg, Germany) speaks to Cardiovascular News at EuroPCR (...
Caner Salih (London, UK) talks to Cardiovascular News about the CardioCel bi...
The clinical frailty score currently used to assess suitability for transcat...
Patients whose prescription for PCSK9 inhibitors (proprotein convertase subt...
Recent low-risk trials for TAVI look set to expand its indications for use. ...
Medtronic has entered into a partnership agreement with Viz.ai to accelerate...
The first patient has been randomised in the TARGET BP I trial at the Piedmo...
Edwards Lifesciences has announced it has made the “difficult decision” to d...
Edwards Lifesciences has issued an urgent safety notice for the latest gener...
According to a statement, Abbott has announced it has received US Food and D...
Women who suffer from idiopathic intracranial hypertension (IIH) have twice ...
Five-year results suggest that surgical aortic valve replacement (SAVR) is a...
Speaking to Cardiovascular News at EuroPCR 2019 (21–24 May, Paris, France), ...
Thanks to the use of robotics in healthcare, many procedures that were once ...
Cardiac Dimensions has announced in a press release that its Caril...
Medtronic has announced plans for a global registry of its HeartWa...
FEops has won the CSI Frankfurt 2019’s Highlight of the Year Award for its F...
After receiving reports of difficulty tracking and manipulating the Centera ...
The Liverpool Centre for Cardiovascular Science, an alliance between academi...
Data from the MeRes-1 and MeRes-1 Extend clinical trials, released at EuroPCR 20...
Admedus has announced positive data from an independent study into the perfo...
PASCAL’s (Edwards Lifesciences) safety and efficacy may rival that of MitraC...
The National Institute for Health and Care Excellence (NICE) has released eviden...
Zoll Medical, an Asahi Kasei Group Company that manufactures medical devices and...
Valix Medical has received a US patent—10,278,820 (percutaneous valve repair...
Robocath has announced that that the well-known interventional cardiologists...
A Philips press release reports both the EPIQ CVx and EPIQ CVxi now include ...
One-year data for the Myval transcatheter aortic valve implantation (TAVI) s...
Siemens Healthineers and Mentice have announced a collaboration to fully integra...
New data show that the use of the investigational HeartFlow Planner—a real-t...
Royal DSM is to collaborate with Strait Access Technologies (SAT) to develop the...
The Centers for Medicare & Medicaid Services (CMS) has finalised its upd...
The OPTION trial is to compare the compare safety and effectiveness of the n...
A company providing what a press release calls “next-generation electrophysi...
2019 saw the 30th anniversary of EuroPCR, with 11,206 participants gathering...
The Society for Coronary Angiography (SCAI) has issued a statement, endorsed...
Adrian Banning (John Radcliffe Hospital, Oxford, UK) initially wanted to fly a B...
New data for the PASCAL system (Edwards Lifesciences), which received the CE mar...
Speaking during an innovation session at TVT 2019 (12-15 June, Chicago, USA)...
This morning at TVT 2019 (12-15 June, Chicago, USA), in separate presentations, ...
Orchestra BioMed and Terumo have formed a global strategic partnership for the d...
Cardiologists can help to reduce the threat of nuclear war and move “the han...
Evolving indications for the use of transcatheter aortic valve implantation ...
The Helix biotherapeutic delivery system (Biocardia), which delivers cell th...
A press release from Biotronik highlights data from the BIOSOLVE-IV registry...
The Cardioform ASD Occluder (Gore Medical) has received US Food and Drug Adm...
Alex Rothman (Sheffield, UK) discusses the TROPHY1 study which looked at the...
The American College of Cardiology (ACC) has announced the appointment of Rann...
This content is only for readers outside of the US as it discusses a device ...
Thomas Modine (Lille, France) talks to Cardiovascular News about the PARTNER...
Royal Philips recently announced the launch of the new IntraSight interventi...
According to a press release, Boston Scientific has initiated the OPTION tri...
Medtronic recently announced the global launch of the Telescope guide extens...
Early experience with the Allegra transcatheter heart valve (New Valve Technolog...
Use of a TriClip (Abbott) for edge-to-edge repair in patients with tricuspid reg...
PCR and the European Association of Percutaneous Cardiovascular Intervention...
Data presented at EuroPCR today indicates that renal denervation with the Sy...
Late-breaking trial data presented at EuroPCR 2019 (20–24 May, Paris, France...
A consensus paper on the use of intracoronary imaging was released at EuroPC...
In our latest edition, new evidence for the use of transcatheter aortic valve im...
In our latest edition, new evidence for the use of transcatheter aortic valve im...
Using the diastolic pressure ratio (dPR) to identify ischaemia-producing les...
ClearFlow medical device company has announced positive clinical trial resul...
A Scientific Statement from the American Association of Cardiovascular and P...
Shockwave Medical has appointed Keith D Dawkins as its chief medical officer...
The AVANCE steerable introducer product family (BioCardia) has received US F...
Cordis, a Cardinal Health company, has announced the full US launch of its Radia...
Abiomed has announced an expanded US Food and Drug Administration (FDA) appr...
The transfemoral approach is—by far—the most desirable access rout...
Nearly two thirds (64.3%) of cath lab staff believe that the financial/administr...
Current US guidelines recommend the use of embolic protection during sapheno...
Patients with ST segment elevation myocardial infarction (STEMI) who undergo...
Ortho Clinical Diagnostics has received the CE mark for its next-generation ...
NeoChord has announced that it has secured additional funding as an extension of...
Biotronik has launched the PK Papyrus covered coronary stent system in the U...
The Virtue (Orchestra BioMed) sirolimus-eluting balloon for the treatment of...
Bardy Diagnostics, provider of ambulatory cardiac monitoring technologies and cu...
Boston Scientific has received US FDA approval for its Lotus Edge transcathe...
TherOx has received US FDA premarket approval for its SuperSaturated Oxygen (SSO...
Tioga Medical—a newly formed Shifamed portfolio company—has announced the closin...
PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS) has announced that the US FDA has ...
An analysis on the impact of stroke severity in patients receiving the Heart...
FEops has received CE mark approval for its FEops HEARTguide. According to a...
Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) ...
Last year, the first two randomised controlled trials (RCT) looking at percu...
A pilot study, published as a research letter in the Annals of Internal Medi...
Between 2000 and 2014, in the USA, the percentage of patients with acute myo...
One-month dual antiplatelet therapy (DAPT) followed by 12 months of clopidogrel ...
Six-month "on-medication" results from the RADIANCE-HTN SOLO clinical trial have...
The European Commission (EC) has approved the use of alirocumab (Praluent, Sanof...
Richard Kovacs has become the new president of the American College of Cardiolog...
Evidence for the use of transcatheter aortic valve replacement (TAVI) as standar...
Toby Rogers (Washington,DC, USA) tells Cardiovascular News that preliminary ...
Robert W Yeh (Department of Medicine, Richard A. and Susan F. Smith Center f...
A subanalysis from the SURTAVI trial has found that transcatheter aortic val...
The AngelMed Guardian implantable device is as safe as using a pacemaker, with c...
The US FDA has approved a new indication for percutaneous edge-to-edge repai...
Micro Interventional Devices chairman, president and CEO, Michael Whitman, and O...
Admedus has received the CE mark for its CardioCel 3D product portfolio and ...
Beginning in mid-2019, hospitals performing transcatheter valve repair and repla...
Carlo Di Mario (Florence, Italy) tells Cardiovascular News at CRT 2019 that...
The renal denervation bubble collapsed due to a single trial—SYMPLICITY HTN...
David Kandzari (Atlanta, USA) tells Cardiovascular News at CRT 2019 that rena...
Boston Scientific announced it has received CE mark and initiated a limited mark...
The commissioner of the US Food and Drug Administration (FDA), Scott Gottlie...
The Peregrine system infusion catheter (Ablative Solutions) has demonstrated...
Northwestern Medicine Bluhm Cardiovascular Institute is pioneering the use of ar...
A press release reports that preliminary data from the BIOSOLVE-IV registry ...
Innovative Cardiovascular Solutions (ICS) has announced the first clinical u...
According to a large observational study presented at Acute Cardiovascular Care ...
Three-year outcome data from the BIO-RESORT randomised controlled trial, whi...
Abbott has announced the US FDA clearance of the resting full-cycle ratio (RFR) ...
The Charing Cross International Symposium (CX) continues its three-year cycle of...
Gary Ansel (Columbus, USA) tells Vascular News at VEITHSymposium 2018 about...
A pooled data analysis comparing the Cre8 amphilimus-eluting stent (Alvimedi...
The Sapien 3 device (Edwards Lifesciences) can be safely and effectively use...
MedAlliance has been granted breakthrough device designation from the US FDA for...
Biotronik, the University of Newcastle (in Australia), and the John Hunter New E...
The American College of Cardiology will expand the Journal of American College o...
At the MWC (25–26 February, Barcelona, Spain), formerly the Mobile World Congres...
Medtronic has received US FDA approval of its Resolute drug-eluting stent pl...
Robocath has obtained CE certification for its R-One robotic device. As a re...
The US FDA have approved Biotronik’s drug-eluting stent Orsiro. A ...
This content is only for readers outside of the US as it discusses a device ...
Recent years have seen many advances in education for cardiologists, but lit...
Mechanical circulatory support is frequently used to stabilise patient haemodyna...
After receiving the CE mark for the device, iVascular launched its Navitian ...
Edwards Lifesciences now has the CE mark for its PASCAL transcatheter mitral val...
The American College of Cardiology (ACC) has launched a new initiative that leve...
Philips Zenition, a new mobile C-arm imaging platform from Philips, has laun...
At the EKOS symposium at LINC 2019, Nils Kucher (Zurich, Switzerland), Houman...
A programme designed to help myocardial infarction patients with the transit...
A review, published in the Journal of the American College of Cardiology, of...
Daniel J Blackman (Department of Cardiology, Leeds Teaching Hospital NHS Tru...
At a press conference held at the National Research Center for Cardiac Surgery i...
The Duke Children’s Pediatric & Congenital Heart Center (Duke University...
In this commentary for Cardiovascular News, Stefan Toggweiler writ...
The Lewisham and Greenwich NHS Trust (London, UK) has become the first NHS T...
A new survey by HeartFlow of more than 1,500 adults across the USA shows onl...
Our latest issue covers the top stories from TCT 2018, including COAPT, ULTIMATE...
Our latest issue covers the top stories from TCT 2018, including COAPT, ULTIMATE...
Teleflex has received premarket approval (PMA) from the US FDA for the Manta...
Vectorious Medical Technologies has announced the initiation of the VECTOR-H...
The PrecludeSync Distal (Merit Medical) is now available in the US, European...
Alvimedica has announced the company has received the CE mark for the Cre8 Evo 2...
Preliminary data from the BIOSOLIVE-IV registry are consistent with the favo...
CAUTION: The ACURATE neo aortic valve system is CE marked. In the USA, it is...
Abiomed has achieved the CE mark for Impella Connect, which—a press release ...
Neovasc has announced that the Institut für das Entgeltsystem im Krankenhaus (In...
The editors-in-chief of major cardiovascular journals—of both US and Europea...
The British Heart Foundation (BHF) has announced that it is now accepting propos...
Experts from the Society for Cardiovascular Angiography and Interventions (SCAI)...
CorMatrix Cardiovascular has received US FDA approval of an early feasibility st...
Martin T Rothman has been appointed as chief medical officer of Vascular Dynamic...
Martin T Rothman has been appointed as chief medical officer of Vascular Dynamic...
Philips launches its Azurion with FlexArm to aid patient imaging and positio...
Three newly published studies highlight the safety, efficacy, and economic a...
It was recently announced that Abbott has exercised its option to purchase Cephe...
The US government shutdown means the country’s Food and Drug Administration ...
Data from the e-MUST study show that the absence of known cardiovascular ris...
New data indicate that patients who develop bundle branch block (BBB) and/or...
HeartFlow has announced the publication of the PACIFIC substudy showing that...
Medical device executive John T Kilcoyne has been appointed as chief executive o...
Shockwave Medical has initiated its US Food and Drug Administratio...
The first patients in the United Arab Emirates (UAE) have been tre...
People who sleep less than six hours a night may be at increased risk of cardiov...
The US Food and Drug Administration (FDA) has approved the Amplatzer Piccolo...
Boston Scientific and Edwards Lifesciences today announced that the companies ha...
Medicaid reimbursement to healthcare facilities on ST-elevation myocardial manag...
The Society of Cardiovascular Computed Tomography (SCCT) has released a new ...
December marked a significant milestone for a major study into the use of sh...
The first US patient has been successfully treated with JC Medical's transfe...
Ryan D Madder (Frederik Meijer Heart and Vascular Institute, Spectrum Health...
A meta-analysis of individual patient-level data from FAME 2, DANAMI-PRIMULT...
Ablative Solutions has announced the first close of its US$77 million Series D f...
It has been announced that the Sapien 3 Ultra system (Edwards Lifesciences) ...
Joseph Lamelas, an internationally recognised expert cardiac surgeon who hel...
US FDA 510(k) clearance has been granted for the FFRangio System (CathWorks)...
Boston Scientific has exercised its option to acquire the remaining shares o...
The first patients in the United States have been treated using the OrbusNeich T...
Writing in Circulation: Cardiovascular Quality and Outcomes, David Ouyang (S...
A post-hoc analysis of FREEDOM (Future revascularisation evaluation in patie...
BioCardia has announced its 510(k) submission for US FDA clearance of the Av...
Merit Medical has announced the release of the Prelude IDeal hydrophilic sheath ...
A jury in the US District Court for the District of Delaware determined that...
A press release reports that Abiomed is to invest US$15 million in Shockwave...
Edwards Lifesciences is to work with Bay Labs on improving the detection of ...
Matthias Meyer (Triemli Hospital, Zurich, Switzerland) and others report in ...
CorPath technology has been successfully used in the first-in-human telerobo...
HeartFlow has announced the start of the PRECISE (Prospective randomised tri...
In draft recommendations, England’s National Institute for Health and Care E...
“The real question is: who should get percutaneous coronary intervention (PCI...
New data, just published in the Journal of the American Heart Association (J...
By Thomas Zeller
The Katsanos et al meta-analysis reports an increased ri...
Sixty years ago, the first pacemaker implant was made in Stockholm, Sweden (...
Reva Medical announced the first implant of its recently launched Fantom Enc...
The first implant of the Pascal mitral valve repair device (Edwards Lifesciences...
Transcatheter aortic valve implantation (TAVI) is now a well-established tre...
JenaValve has received US FDA approval of expansion of its investigational d...
Ulf Näslund (Umeå University, Umeå, Sweden) and others report in The Lancet ...
Quidel has received the CE mark for its TriageTrue high sensitivity troponin I t...
WeHealth by Servier, Servier Group’s e-health Business unit, and MobioSense, a l...
The American College of Cardiology New York Cardiovascular Symposium will be hel...
Quentin Fischer (Department of Cardiology, Quebec Heart and Lung Institute, ...
At the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meeting (21–25 S...
Insufficient blood flow towards the coronary vasculature following transcath...
The US FDA has announced plans to modernise its 510(k) clearance programme f...
More than ever before, arterial hypertension represents one of the greatest ...
The study of stem cells in regenerative medicine is a growing field of basic...
Artificial intelligence (AI) is already better than humans at reading specifi...
The results of the meta-analysis pooling all existing randomised controlled ...
According to the results of PADN-5, pulmonary artery denervation (PADN) is a...
John A Dodson (New York University School of Medicine, New York, USA) and ot...
The CE mark has been granted to the Sapien 3 Ultra (Edwards Lifesciences) tr...
Bay Labs and Northwestern Medicine have announced that the first patient has...
The Japanese Ministry of Health, Labor and Welfare (MHLW) has approved the recom...
Ron Waksman
The Lipid Rich Plaque (LRP) study indicates that cardiac pat...
Data from the EARLY randomised trial indicate that patients with non-ST-segm...
A pilot study comparing a strategy of left ventricular unloading with the Im...
In this video from the European Society of Cardiology, Roxana Mehran (Zena and M...
The FDA have given Medtronic approval to begin a clinical trial to evaluate ...
Vivasure Medical has announced the European launch of the PerQseal closure d...
NeoChord has announced that it has completed a US$25 million Series D equity...
An international study, led by researchers from the Intermountain Medical Ce...
The first patient in Hong Kong has been treated with the Diamondback 360 cor...
BioCardia has announced that Mark Schwartz—a 25-year veteran of cardiovascular d...
REDUCE-FMR indicates that indirect annuloplasty with the Carillon device (Ca...
Cordis, a Cardinal Health company, has launched its Mynx Control vascular cl...
Reva Medical announced the commercial launch of the Fantom Encore bioresorba...
4TECH has initiated its US early feasibility study, following receipt of app...
A new study indicates that low air temperature, low atmospheric air pressure...
A new meta-analysis of patients undergoing percutaneous closure of patent fo...
According to a press release, Raimondo Ascione, Saadeh Suleiman (Bristol Hea...
CellProThera and BioCardia announced an agreement to expand their current co...
Data from the TriValve Registry—an international multicentre, retrospective,...
The largest study to date of prosthesis-patient mismatch following transcath...
The collaboration agreement between iVascular and NaviGate Cardiac Structure...
The HeartMate 3 left ventricular assist device has received US FDA approval ...
At Asia Pacific MedTech Forum 2018 (9-10 October, Singapore), Cambridge Cons...
Micro Interventional Devices announced the world's first percutaneous implantati...
Caristo Diagnostics, an Oxford University spinout company, has been launched to ...
Rivaroxaban, brand name Xarelto (Janssen), has received approval by the US F...
A new study indicates that transcatheter mitral valve implantation (TMVI) wi...
Tushar Acharya (National Heart, Lung, and Blood Institute, National Institut...
Transseptal Solutions has received FDA 510(k) clearance for its TSP Crosser ...
Teleflex has acquired Essential Medical, which has developed and commerciali...
This content is only for readers outside of the USA
First real-world case exp...
Edwards Lifesciences has commenced the US pivotal trial that will study its ...
Research presented at the 29th Great Wall International Congress of Cardiolo...
Jun-jie Zhang (Department of Cardiology, Nanjing First Hospital, Nanjing Med...
UK-based charity Heart Research UK has given a Novel and Emerging Technologies (...
The revised European Society of Cardiology (ESC) myocardial revascularisatio...
This content is only for readers outside of the US as it discusses a device ...
Olaf Wendler (lead for Cardiothoracic Surgery, King’s Health Partners, and cha...
Venus Medtech has signed an agreement to acquire Keystone Heart, a privately-hel...
The Society for Cardiovascular Angiography and Interventions (SCAI) has anno...
Two-year data from the BIOFLOW-V randomised trial—which compared a sirolimus...
According to one-year results from the PORTICO I study, which were presented dur...
New data presented at 2018 Transcatheter Cardiovascular Therapeutics (TCT) m...
A new analysis of data from the Impella (Abiomed) Quality (IQ) Database show...
The primary endpoint results of the LEADERS FREE II trial were presented at ...
Data presented at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) m...
The FAST-FFR trial, which was presented at the 2018 Transcatheter Cardiovasc...
Delegates at the 2018 Transcatheter Cardiovascular Therapeutics (TCT) meetin...
Data presented yesterday at the 2018 Transcatheter Cardiovascular Therapeuti...
In our latest issue, we report on the top stories from the 2018 ESC Congress—inc...
In our latest issue, we report on the top stories from the 2018 ESC Congress—inc...
The US FDA has approved an investigational device exemption (IDE) to initiat...
Cardiac Dimensions has announced the company has randomised its first patient in...
Speaking at PCR London Valves (9–11 September, London, UK) Didier Tchétché (Clin...
Data from the multicentre FAST-TAVI trial indicate that early discharge—disc...
A new study evaluating the safety and performance of the Acurate neo2 (Bosto...
Medtronic has announced the start of the Onyx ONE Clear Study in the USA and...
The US FDA has approved the PK Papyrus covered coronary stent system (Biotro...
Two patients have been successfully treated with Millipede’s latest-generation d...
Results from the highly anticipated LRP (Lipid-Rich Plaque) study will be pr...
Corindus Vascular Robotics is to feature its CorPath GRX system at the 2018 ...
The Society for Cardiovascular Angiography and Interventions (SCAI) has announce...
BTG has announced it has acquired Novate Medical (“Novate”), a medical device co...
Gore has acquired Pipeline Medical Technologies—a privately held medical technol...
Vascular Dynamics has revealed that enrolment of the first patients in an FD...
New results from the TMVR (Transcatheter mitral valve replacement) Registry ...
SIS Medical is to launch three new models of its balloon catheters—EasyT, NIC 1....
Hiroto Yabushita and colleagues report in Circulation: Cardiovascular Interv...
Bjarne L Nørgaard (Department of Cardiology, Aarhus University Hospital, Aar...
Amit N Vora (Duke University Medical Center/the Duke Clinical Research Insti...
The LRT (Low Risk TAVR) trial did not find any significant differences in th...
Milind Desai (Cleveland Clinic, Cleveland, USA) and colleagues have identified a...
One-year follow-up data from the REDUCE LAP-HF I clinical study of the Interatri...
One-year data from the CULPRIT-SHOCK trial indicate that there is no significant...
The GLOBAL LEADERS trial, simultaneously published in the Lancet and present...
The 12-months results of the BASKET-SMALL 2 study, which were presented at the 2...
According to the five-year results of the BIOSCIENCE trial, sirolimus-elutin...
This content is only for readers outside of the USA
In an environment wit...
The first randomised controlled trial to compare percutaneous edge-to-edge r...
Recently the Centers for Medicare and Medicaid Services (CMS) reopened the N...
The final results of the FUTURE (Functional testing underlying revascularisa...
Thomas S Gilhofer (University Heart Center, Department of Cardiology, Univer...
A new study has found that the dual antiplatelet therapy (DAPT) score, which...
Data from the Canadian Spontaneous Coronary Artery Disease (CanSCAD) study i...
At the 2018 European Society of Cardiology (ESC) Congress (25–29 August, Mun...
Cerner has collaborated with Duke Clinical Research Institute to develop the ath...
At the 2018 European Society of Cardiology (ESC) Congress (25–29 August, Munich,...
WeHealth, by Servier, has launched Cardioskin—a connected solution that is desig...
Xarelto, co-administered with aspirin, is indicated in the EU for the preven...
RenalGuard Solutions has announced the treatment of 20,000 patients with Ren...
More than 100,000 people have been trained in hands-only cardiopulmonary res...
Juan F Granada (president and CEO, Cardiovascular Research Foundation, New Y...
ClearFlow has been awarded a group purchasing agreement—chest drainage contract:...
Philips has introduced the EPIQ CVx cardiovascular ultrasound system. Built on t...
In this edition (Issue 50), we report on the key studies from EuroPCR 2018—SPYRA...
In this edition (Issue 50), we report on the key studies from EuroPCR 2018—SPYRA...
This content is only for readers outside of the US as it discusses a device ...
In a new position paper, published in the European Heart Journal, the Sports...
A feasibility study of a novel left atrial appendage device (Ultraseal, Card...
Rafael A Meneguz-Moreno (Department of Interventional Cardiology, Instituto ...
Data from OPTIMIST (Options in myocardial ischemic syndrome therapy) registr...
The US FDA has sent a letter to transplant surgeons and cardiologists about ...
CathWorks has announced that its FAST-FFR trial is fully enrolled ahead of s...
The first study to compare the use of transcatheter aortic valve implantatio...
A new study, published in JAMA Network Open, indicates that patients with at...
Chun Shing Kwok (Keele Cardiovascular Research Group, Keele University, Stro...
A new study published in Mayo Clinical Proceedings indicates that the rate of ac...
Brad N Greenwood (Carlson School of Management, University of Minnesota-Twin...
At present, a bicuspid aortic valve is seen as a relative contradiction for ...
JenaValve has announced initiation of patient enrolment in its early feasibi...
LivaNova has announced the conclusion of the PRELUDE feasibility study for its C...
The manuscript “Safety and efficacy of the Reducer: A multicentre clinical r...
Boston Scientific has announced that it has recently closed its acquisition of C...
Researchers have found that people exposed to air pollution levels well within U...
VisCardia has announced the first implant of its VisONE implantable system f...
Integer Holdings has received US FDA and CE mark approval for its new radial...
Infraredx has announced the Makoto intravascular imaging system, and accompa...
Medtronic has received US FDA approval for its implantable system for Remodulin ...
The Committee for Medicinal Products for Human Use (CHMP) of the European Medici...
A study in EuroIntervention indicates that very elderly patients—mean age 84...
Chun Wai Wong (Cardiovascular Research Group, Keele University, Stroke-on-Tr...
A Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) pan...
Abbott has initiated a pivotal clinical study in the USA of its Tendyne tran...
Siemens Healthineers has announced it is helping to shorten the time doctors...
Data from PARAMEDIC2 (Prehospital assessment of the role of adrenaline: Meas...
Yequn Chen (Department of Cardiology, First Affiliated Hospital of Shatou Un...
Corindus Vascular Robotics has announced that Ryan Madder (Spectrum Health, ...
Cook Regentec has announced the first clinical use in the USA of the Advance CS ...
Boston Scientific has signed an agreement to acquire Claret Medical, which devel...
Reva is expanding commercial access to the Fantom bioresorbable scaffold wit...
The new EU Medical Device Regulation (MDR) was officially published on 5 May...
Cardiovascular Systems, Inc. (CSI) has signed an exclusive international dis...
The 2018 American Association for Thoracic Surgery (AATS), the American College ...
A new cardiac diagnostic device (Vitalscan) aimed at helping physicians rule...
Visura Technologies has received 510(k) clearance from the US FDA for its tr...
MedShr, which now has more than 500,000 physician users in 180 countries, is...
Given sufficient time, all bioprosthetic valves fail—whether they are surgic...
Abbott has received approval from the US FDA for a next-generation version o...
The first propensity-matched comparison between the transaortic approach and...
New data from the FRAILTY-AVR study indicate that mortality—both at 30 days ...
A press release reports that the CALYPSO programme will receive 14 million e...
CathWorks has received a new CPT code 0523T for its non-invasive, 3D FFRangi...
Otsuka Holdings, Otsuka Medical Devices, and ReCor Medical have signed a mer...
Researchers funded by the British Heart Foundation have identified how a new...
This content is only for readers outside of the US as it discusses a device ...
In a “Call to action”, published in the Journal of American College of Cardi...
A new study indicates that transcatheter aortic valve implantation (TAVI) wi...
Medtronic has received United States Food and Drug Administration (FDA) approv...
A 24-day old infant has received the first-in-human placement of BeGrow (Bentl...
The diagnosis of acute myocardial infarction and, therefore, chest pain tria...
The largest study to date to systematically review outcomes associated with ...
CorWave has announced that it has obtained patent no. US 9,968,720 B2 on May 15,...
According to a study published in Radiology, cardiac hybrid imaging with compute...
The RADIANCE-II study of the Paradise Ultrasound Denervation System (ReCor M...
Endotronix has announced they have joined the American Heart Association’s Cente...
Lexington Biosciences has announced the completion of the initial HeartSentry st...
BTG has announced a strategic partnership with the PERT Consortium to advanc...
HeartFlow has announced that UnitedHealthcare now covers its HeartFlow FFRct...
AorTech, a biomaterials and medical device IP company, has signed a development ...
The American College of Cardiology’s (ACC) ACTION Registry is changing its n...
Neovasc announced that its Tiara transcatheter mitral valve implantation (TM...
Kenichi Takahata (University of British Columbia, Vancouver, Canada) and col...
Second-generation drug-eluting stents resolved the issues of late and very l...
A new study, published in Circulation: Cardiovascular Interventions, shows t...
This content is only for readers outside of the US as it discusses a device ...
Results from the SAFE MANTA IDE clinical trial—the first pivotal trial for a...
The annual census of UK consultants and higher speciality trainees—Focus on ...
JenaValve Technology has announced the initiation of patient enrolment and i...
According to a study published in LGBT Health, bisexual men have a higher ri...
Steven Farmer (Center for Healthcare Innovation and Policy Research, George ...
A pre-specified analysis of the TROPICAl-ACS study indicates that de-escalat...
Keystone Heart announced the launch of phase II of the REFLECT trial, which ...
Ron Waksman (MedStar Heart & Vascular Institute, Washington, DC, USA) is...
Bay Labs has received US FDA 510(k) clearance for its EchoMD AutoEF software...
Caladrius has revealed that the US FDA has granted regenerative medicine advance...
A new study, SYNTAX III REVOLUTION, has found heart teams using computed tom...
A new study indicates that a delayed approach in patients with transient ST-...
According to Anja Stundl (Department of Medicine II, Heart Center Bonn, Univ...
In this PCR video, David E Kandzari (Department of Interventional Cardiology, Pi...
New data from ADAPT-DES, published in JACC: Cardiovascular Interventions, in...
Hermann Reichenspurner (Departments of Cardiovascular Surgery and General an...
Corindus Vascular Robotics has received Pharmaceutical and Medical Device Ag...
The NOTION trial (Nordic aortic valve intervention) was the first comparison...
Countries in the European Union have long been the first to receive new innovati...
Thirty-day data presented at EuroPCR (22 May—25 May, Paris, France) show con...
The American College of Cardiology (ACC), Heart Rhythm Society (HRS), North ...
Five-year data from FAME (Fractional Flow Reserve vs. Angioplasty for Multiv...
According to a study published in BMJ Open, just over half of patients think...
For our May 2018 edition (Issue 49), we report on the key studies from the 2018 ...
For our May 2018 edition (Issue 49), we report on the key studies from the 2018 ...
Data presented at the British Cardiovascular Society Conference (4–6 June, Manch...
Biomerics has bought FutureMatrix Interventional, which specialises in the desig...
The US FDA has classified Medtronic’s recent voluntary urgent field action r...
New data from the ORBITA trial indicates percutaneous coronary intervention ...
Compared with first-generation devices, new-generation transcatheter aortic ...
At EuroPCR (22 May–25 May, Paris, France), the 12-month results of the ANGIO...
The clinical results from the OxAMI-PiCSO study—published in EuroInterventio...
The European Commission (EC) has authorised a new indication in the evolocum...
Amaranth Medical provided an update on its sirolimus-eluting bioresorbable scaff...
CeloNova BioSciences has announced one-year clinical trial results from the ...
Two-year outcome data from the BIO-RESORT randomised controlled trial, which...
Investigators unveiled clinical data from the independently run Onyx 1-Month...
Alvimedica unveiled the details of the Diab8 study—the first diabetic drug-eluti...
This content is for distribution within the UK only.
This content is ...
Abbott has announced it has received approval from the US FDA for its Xience...
Data presented during EuroPCR (22 May – 25 May, Paris, France) provide furth...
After two studies indicated that renal denervation lowers blood pressure bot...
New data from the PACIFIC study presented at EuroPCR (22 May – 25 May, Paris, Fr...
Intravascular Lithotripsy (Shockwave Medical) is now available, on the European ...
A press release reports that the first patient to receive the GATE tricuspid val...
Ancora Heart has announced the expansion of its US feasibility study to eval...
Boston Scientific Corporation has revealed its schedule of key presentations...
CoreMedic has announced the start of the first-in-man Chagall study to evaluate ...
Medtronic has announced the initiation of a clinical study in the US to asse...
Pi-Cardia has recently started its first-in-human study with its Leaflex Perform...
A new study shows that patients who undergo percutaneous coronary interventi...
Erik W Holy (Heart Center, Segeberger Kliniken, Bad Segeberg, Germany) and o...
Cardiac Dimensions has appointed Matthew Stark as vice president of clinical and...
Abbott has announced that Japan’s Ministry of Health Labour and Welfare (MHLW) h...
According to a study published in Circulation, among more than 230,000 cardi...
Edwards Lifesciences has received the CE mark for the Cardioband tricuspid v...
David A Cox, (Brookwood Baptist Health, San Antonio, USA; Cardiovascular Associa...
A new study presented at the 2018 Society for Cardiovascular Angiography and...
Speaking at the 2018 CRT meeting (3–6 March, Washington, DC), Victor Alfonso...
Patients who require non-emergent, uncomplicated target lesion revascularisa...
One-year outcome data for transcatheter mitral valve implantation (TMVI), in...
Terumo has received the CE mark for its Ultimaster Tansei drug-eluting stent...
Root cause analysis of radial occlusion points to vessel trauma. An ultrasound s...
A review of the trends in the use and propensity-matched analysis of in-hosp...
Roberto Canessa is one of 16 survivors from Uruguayan Air Force Flight 571, ...
The COBRA REDUCE trial is exploring the safety and efficacy of prescribing d...
Intravascular lithotripsy, or IVL (Shockwave), is a novel procedure that is ...
According to a press release, Boston Scientific has, along with several othe...
A press release reports that HeartStitch transapical access and closure device p...
Medtronic has announced that Laura Mauri—interventional cardiologist and clinica...
New data show that, after a myocardial infarction, significantly fewer women...
Supporting the results of previous studies, a new study indicates that percu...
A new study indicates that just over a third of patients with cardiovascular...
Abbott has initiated the landmark GUIDE-HF clinical trial using the CardioME...
Abiomed has received US FDA premarket approval (PMA) for its Impella CP hear...
Following the results of the Gore REDUCE clinical study, which found that cl...
Medtronic has announced US FDA approval to begin an investigational device e...
A press release reports that successful patient enrolment in the CE mark stu...
Nine and 12-month data for Orsiro—presented by Yang Yue Jin (Fu-Wai Hospital...
Edwards Lifesciences has announced that enrolment is complete in the compute...
Colibri Heart Valve has announced that the first two patients have been succ...
Acurate neo
Boston Scientific has announced the UK Court of Appeal dism...
The European Hospital in Rome has become the first site in Italy to participate ...
Justin Davies (Imperial College London, London, UK) has always been interest...
According to a new study, the higher rate of all-cause mortality after percu...
Data from the YOUNG-MI registry indicate that 10% of young myocardial infarc...
Transcatheter aortic valve implantation (TAVI) has progressed from being a p...
Data from the SMART-DATE study indicate that acute coronary syndrome patient...
A new study—presented at the American College of Cardiology (ACC) Scientific Ses...
Data indicate that patients who undergo TAVI with the Sentinel Cerebral Protecti...
Biotronik has announced that patient enrolment for the BIOSTEMI study has be...
Economic data from the DEFINE FLAIR clinical trial indicate that using instantan...
New data from the CoreValve US Pivotal Extreme Risk Study and the real-world...
The US FDA has approved the Masters HP 15mm rotatable mechanical heart valve...
Umesh Khot (Cleveland Clinic, Cleveland, USA) and colleagues found that implemen...
The ODYSSEY OUTCOMES trial met its primary endpoint, demonstrating that high-ris...
C Michael Valentine is the new president of the American College of Cardiolo...
Cardiovascular Systems has announced that the US FDA has granted 510(k) clea...
HeartFlow has entered into a licensing and technology transfer agreement with Ce...
Data from the FITT-STEMI (Feedback intervention and treatment times in ST-se...
Registry data for younger patients—under 75 years—undergoing transcatheter a...
Karl-Heinz Ladwig (Technical University of Munich and Helmholtz Zentrum Münc...
According to a press release, Reva Medical has received the CE mark for its ...
According to a study presented at the American College of Cardiology’s Cardiovas...
Designed specifically for small vessels, the Resolute Onyx 2mm drug-eluting ...
In this edition of Cardiovascular News (issue 48, US edition), we report on the ...
In this edition of Cardiovascular News (issue 48), we report on the top stories ...
The Food and Drug Administration (FDA) has today issued the final rule on “h...
Edwards Lifesciences has received the CE mark for its self-expanding Centera tra...
Felix Weise (Cardioangiologisches Centrum Bethanien, Frankfurt, Germany) and...
New data from the EXCEL trial, which found that percutaneous coronary interv...
Since it received FDA clearance in June 2017, the Sentinel cerebral protecti...
Abiomed has received an expanded US FDA premarket approval for the Impella 2...
The first patient has been enrolled in a clinical trial evaluating 28 days o...
LivaNova has entered into an agreement to acquire TandemLife, a privately held c...
Somahlution has announced that Golden Jubilee National Hospital and Victoria Bla...
According to an American College of Cardiology (ACC) press release, hundreds...
A new subanalysis of the phase III PEGASUS-TIMI 54 trial indicates that tica...
BioVentrix has announced a significant reimbursement achievement. InEk, the ...
BTG reported that the OPTALYSE PE one-year trial results, presented at ISET (3–5...
Thomas Munzel (Department of Internal Medicine, University Medical Center Mainz,...
At the 2018 Joint EuroCMR/SCMR meeting (31 January–3 February, Barcelona, Spain)...
HeartFlow has revealed that seven new commercial payers issued positive medi...
Data from the FRALITY-AVR (Frality aortic valve replacement) study suggest t...
Jeffrey C Kwong (Institute for Clinical Evaluative Sciences, Toronto, Canada...
Robocath—a company that conceives and develops cardiovascular robotic system...
BioCardia has announced that the US FDA has approved an investigational device e...
According to a press release from Tryton Medical, the first patient has been...
Corindus Vascular Robotics will be co-sponsoring courses at multiple leading...
Surmodics has received US FDA 510(k) clearance for its Telemark .014inch coronar...
Uchenna R Ofoma (Geisinger Health System, Danville, USA) and others report i...
Boston Scientific has closed an investment and entered into an acquisition o...
According to a Biotronik press release, the Japanese Ministry of Health has ...
The European Society of Cardiology (ESC) has released a new video, see below, th...
An all-comers study of patients undergoing percutaneous coronary interventio...
Patients who undergo transfemoral transcatheter aortic valve implantation (T...
Nearly a quarter of patients with chronic ischaemic cardiovascula...
Cordis and Medinol have announced that the first US commercial cases using t...
Corindus Vascular Robotics has announced that it is working with Mayo Clinic...
The Christ Hospital, Lindner Research Center in Cincinnati, USA, has enrolled th...
The results of PRECLUDE, an analysis of data from the ongoing SWEDEHEART qua...
Endotronix has announced successful first-in-human implantation of the Corde...
Acarix started the initiation of a multicentre trial of its handheld CADScor...
Essential Medical has announced the completion of the 60-day follow up for i...
A meta-analysis, published in The American Journal of Medicine, provides fur...
Miracor Medical Systems and Miracor Medical have announced the closing of € ...
A meta-analysis—published in Circulation Cardiovascular Interventions—indica...
Andrew Goldsweig (Division of Cardiology, University of Nebraska Medical Cen...
According to a press release, a first-in-man feasibility study focusing on a...
The Science Museum (London, UK) has unveiled a special exhibit to commemorat...
HeartFlow has announced that the Health Care Service Corporation (HCSC)—that...
Janssen has submitted a supplemental new drug application to the US FDA for ...
Apple has launched the Apple Heart Study app, a first-of-its-kind research study...
The American Heart Association (AHA) has named attorney M Lewis Kinard as ex...
Philips has acquired VitalHealth, a provider of cloud-based population health ma...
Edwards Lifesciences Corporation today announced it has acquired Harpoon Medical...
4C Medical Technologies has won the Best Technology Parade Presentation award—at...
The iSTEMI study, published in JACC: Cardiovascular Interventions, suggests ...
Fan Chung (National Heart & Lung Institute, Imperial College London, UK)...
According to the interim results of the first-ever multi-country online surv...
Avinainder Singh (Brigham and Women’s Hospital, Harvard Medical School, Bost...
Data from the regional emergency cardiovascular (RESCUe) network indicate th...
CorInnova has been awarded second prize in the “2017 InnoSTARS” life science...
The HREVS (Hybrid coronary revascularisation vs. standard) trial found that ...
Following ORBITA, which indicated percutaneous coronary intervention (PCI) d...
The US FDA has approved evolocumab (Repatha, Amgen) for the prevention of my...
Data from the ABSORB IV study indicate that device thrombosis with the biore...
We are witnessing a new era in which artificial intelligence is being applied to...
A report—modified from US global health recommendations from the National Academ...
Cordis and Medinol have announced that the US FDA has approval the Elunir dr...
NeuroproteXeon has announced the publication of a second finding from a randomis...
The first human implantation of the VenusA Plus retrievable valve system was...
The Society for Cardiovascular Angiography and Interventions (SCAI) has laun...
The past few years has witnessed increasing clinician engagement with social...
Boston Scientific has announced a delay to the previously communicated timel...
Joseph Ladapo (David Geffen School of Medicine, University of California, Los An...
Data from the MITRAL (Mitral Implantation of Transcatheter valves) study ind...
Boston Scientific has announced the final five-year outcomes data from the P...
Francesco Maisano (University Heart Centre, University Hospital Zurich Zuric...
Data from PRESERVE (Prevention of serious adverse events following angiograp...
Primary results from the REDUCE LAP-HF trial indicate that a novel interatri...
Creavo Medical Technologies (Creavo) has won two awards at the Ins...
The ORBITA (Objective randomised blinded investigation with optimal medical ...
A study published in the Journal of the American College of Cardiology indicates...
Corvia Medical has enrolled the first patients in its global multicentre trial (...
Stentys has announced the precommercialisation of its Serpentis stent. According...
Philips has announced the results of a comprehensive, independent, two-year ...
Data published, as a research letter, in the Journal of the American College...
Neovasc has received approval of the US FDA to initiate the COSIRA-II IDE clinic...
ORBITA (Objective randomised blinded investigation with optimal medical ther...
Advice on percutaneous coronary intervention (PCI) strategies for patients w...
Abbott has announced that Japan's Ministry of Health, Labour and Welfare (MH...
HeartFlow has announced that the Centers for Medicare & Medicaid Service...
Elixir Medical unveiled for the first time its novel stent technology—Dynamx...
Data presented during the 2017 Transcatheter Cardiovascular Therapeutics (TC...
Acist has announced the global launch of its RXi Mini system—the next-generation...
The primary results from the DAPT-STEMI trial suggest that 12-month dual ant...
In this video, hear how key recommendations from the 2017 ESC/EACTS Guidelines f...
The Fantom bioresorbable scaffold (Reva Medical) shows continued positive cl...
Early experiences with two transcatheter mitral valve implantation (TMVI) de...
Olivier Varenne (Hôpital Cochin, Assistance Publique—Hôpitaux De Paris, Pari...
David Cohen (Saint Luke’s Mid America Heart Institute, Kansas City, USA) has...
New clinical research, presented today at the 2017 Transcatheter Cardiovascula...
New results from the HARMONEE Japan/US registration trial, which were presente...
The CE mark has been awarded to a new-generation of Abbott Vascular's everol...
New data from the ongoing CADLAD (Coronary artery disease learning and algorithm...
Highlights:
SPYRAL HTN-OFF MED provides "proof of principle" that renal den...
Highlights:
SPYRAL HTN-OFF MED provides "proof of principle" that renal den...
Bay Labs, a medical technology company developing an artificial intelligence in ...
A team at the Technical University of Munich (TUM) has determined that in the fi...
Nitiloop has received FDA clearance for its new Nova Cross Extreme and Nova Cros...
The US FDA has approved the expansion of CeloNova’s ongoing clinical trial of it...
David Montaigne (University of Lille, France) and others report in The Lance...
A new study indicates that long-term exposure to elevated blood pressure is ...
Data from the TRANSLATE-ACS (Treatment with adenosine diphosphate receptor i...
In Scientific Reports, a Nature publication, Julien Bec (Department of Biome...
Boston Scientific has announced key data will be presented at next week’s Tr...
Claret Medical has announced that it has closed on a series C financing of U...
The first patient in the APOLLO trial has undergone transcatheter mitral val...
Micro Interventional has announced that the second successful implantation of it...
Everolimus-Eluting Platinum Chromium Coronary Stent System
Drug-eluting s...
Data presented at the 8th Emirates Cardiac Society congress (19–21 October, ...
Thomas Haldis (Sanford Health, Fargo, USA) and others report in EuroInterven...
Reva Medical has announced the commercial expansion of its bioresorbable sca...
Elixir Medical has revealed details of its programme and activities during the 2...
